Relay Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Relay Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2019 to Q3 2024.
  • Relay Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $22.5M, a 2.97% increase year-over-year.
  • Relay Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $95.8M, a 18.9% increase year-over-year.
  • Relay Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $86M, a 53.2% increase from 2022.
  • Relay Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $56.1M, a 15.9% increase from 2021.
  • Relay Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $48.5M, a 51.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $95.8M $22.5M +$649K +2.97% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $95.1M $26.8M +$3.42M +14.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $91.7M $27.2M +$5.67M +26.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $86M $19.3M +$5.45M +39.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $80.6M $21.8M +$8.12M +59.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $72.5M $23.4M +$8.26M +54.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $64.2M $21.5M +$8.06M +59.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $56.1M $13.8M +$3.6M +35.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $52.5M $13.7M +$1.3M +10.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $51.2M $15.1M -$1M -6.19% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $52.2M $13.5M +$3.78M +39.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $48.5M $10.2M -$4.33M -29.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $52.8M $12.4M +$489K +4.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $52.3M $16.1M +$12.1M +300% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $40.2M $9.67M +$8.22M +565% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $32M $14.5M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $11.9M +$10.7M +856% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $4.03M +$2.95M +271% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $1.46M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2019 $1.25M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $1.09M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.